LHDX News and Press, Lucira Health Inc. From 03/10/22

Lucira Health, Inc. (LHDX) Q4 2021 Earnings Conference Call March 10, 2022, 04:30 PM ET Company Participants Greg Chodaczek - Gilmartin Group, IR Erik Engelson - President, CEO Dan George - CFO Conference Call Participants Derik De Bruin - Bank of America Merrill Lynch Griffin Soriano - Willi...

Image source: The Motley Fool. Lucira Health, Inc. (NASDAQ: LHDX) Q4 2021 Earnings Call Mar 10, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Lucira Health, Inc. (LHDX) Q4 2021 Earnings Call Transcript

Lucira Health press release (NASDAQ:LHDX): Q4 GAAP EPS of -$0.20 beats by $0.29. Revenue of $61.12M (+23407.7% Y/Y) beats by $14.22M. For further details see: Lucira Health GAAP EPS of -$0.20 beats by $0.29, revenue of $61.12M beats by $14.22M

EMERYVILLE, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health,” “Lucira” or the “Company”), a medical technology company focused on the development and commercialization of transformative and innovative in...

Lucira Health went public in February 2021, raising $153 million in an IPO. The firm is developing various infectious disease testing kits. Its first kit, for COVID-19, has produced rapidly growing revenue since launch. LHDX is still seeking to diversify its revenue streams, s...

EMERYVILLE, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, to...

EMERYVILLE, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that on Februa...

Lucira™ Health Commits 2 Million At-Home Molecular COVID-19 Test Kits on Amazon Lucira Health's rapid accurate molecular at-home test is available for purchase nationwide with fast, free delivery through Amazon Prime PR Newswire EMERYVILLE, Calif. , Feb....

Lucira's COVID-19 test is the only EUA authorized rapid at-home self-test that delivers PCR accuracy and early detectability in a single-use test kit with results in 30 minutes Availability in the Optum Store expands access to this unique testing option amidst a surge of US ...

EMERYVILLE, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced preliminary revenue results for t...